Table 1 Patient characteristics
Characteristic | Groupa | P | |
|---|---|---|---|
Control (n = 40) | Rejection (n = 25) | ||
Age, y | 53.2 (11.5) | 48.4 (13.5) | .15 |
Time since transplant, y | 0.98 (0.08) | 1.13 (1.3) | .47 |
Men | 30 (75) | 16 (64) | .34 |
BMI, kg/m2 | 25.96 (5.0) | 25.96 (5.9) | .99 |
BSA, m2 | 1.94 (0.26) | 1.87 (0.25) | .26 |
Hypertension | 17 (44) | 12 (45) | .73 |
LDL cholesterol, mg/dL | 103.0 (32.47) | 104.9 (39.15) | .57 |
Diabetes mellitus | 8 (20) | 3 (12) | .40 |
SBP, mm Hg | 126.3 (15.3) | 126.5 (15.5) | .95 |
DBP, mm Hg | 76.3 (11.3) | 79.1 (10.0) | .30 |
Heart rate, beats/min | 90.2 (11.2) | 94.5 (11.4) | .15 |
Hyperlipidemia | 20 (50) | 16 (64) | .27 |
QRS duration, ms | 106.6 (19.5) | 103.7 (25.6) | .61 |
Cyclosporine, n (%) | 16 (40) | 14 (56) | .21 |
Tacrolimus, n (%) | 7 (18) | 5 (20) | .84 |
Sirolimus, n (%) | 19 (48) | 9 (36) | .34 |
Azathioprine, n (%) | 8 (20) | 4 (16) | .69 |
Mycophenolate mofetil, n (%) | 25 (63) | 21 (84) | .07 |
Prednisone in last 12 months, n (%) | 38 (95) | 21 (84) | .14 |
ACE-I/ARB, n (%) | 16 (40) | 6 (24) | .19 |
Beta-blocker, n (%) | 5 (13) | 2 (8) | .54 |
Statin, n (%) | 20 (50) | 16 (64) | .27 |